<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05049941</url>
  </required_header>
  <id_info>
    <org_study_id>6382021</org_study_id>
    <nct_id>NCT05049941</nct_id>
  </id_info>
  <brief_title>Blood Gases Versus Lactate Clearance as an Indicator of Initial Resuscitation in Septic Patients: Comparative Study</brief_title>
  <official_title>Blood Gases Versus Lactate Clearance as an Indicator of Initial Resuscitation in Septic Patients: Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      - This perspective blind randomized single center study was designed to assess central venous&#xD;
      and arterial gases level including P(v-a)CO2/C(a-v)O2 ratio and P(v-a)CO2 difference against&#xD;
      lactate clearance as an indicator of initial resuscitation in septic patients in intensive&#xD;
      care unit and to evaluate the success of early resuscitation protocol .this continuation of&#xD;
      our previous work we compared the ratio of P(v-a)CO2/C(a-v)O2 ratio against lactate&#xD;
      clearance(8). Mortality in the ICU in the study groups will be recorded&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      On ICU admission, Criteria of Systemic Inflammatory Response Criteria (SIRS) were evaluated&#xD;
      including: abnormal white blood cell count &gt;12,000/ μL or &lt;4000/ μL, heart rate &gt;90/min,&#xD;
      respiratory rate &gt;20/min or PaCO2 &lt; 32 mmHg or abnormal body temperature &gt;38.3 °C (100.4 °F)&#xD;
      or &lt;36 °C (96.8 °F). The quick Sequential Organ Failure assessment (qSOFA) score (10)&#xD;
      measured at the bedside : altered level of consciousness (Glasgow Coma Scale score ≤ 13),&#xD;
      Systolic blood pressure &lt; 90 mmHg and respiratory rate ≥ 22 rpm. The Acute Physiology and&#xD;
      Chronic Health Evaluation (APACHE II) score were collected (Knaus et al.,1985). Patients&#xD;
      monitoring of heart rate, pulse oximetry, invasive arterial blood pressure for measurement of&#xD;
      MAP, core temperature (UltraviewSL2700; Spacelaps, USA). and urine output. Laboratory&#xD;
      investigations includes: complete blood count, C-reactive protein, liver and renal functions,&#xD;
      coagulation profile, blood glucose, sodium and potassium level. All patients had jugular&#xD;
      central venous catheter was inserted under ultrasound guidance, and the position confirmed by&#xD;
      chest radiograph, then central venous pressure (CVP) was measured before starting the initial&#xD;
      resuscitation (T0) ansd 8 hours after resuscitation (T8). From CVP line, blood sample&#xD;
      analyzed by (SIEMENS RAPIDPoint® 500 blood gas machine). The following measurements were&#xD;
      recorded at (T0) and at (T8): Central venous oxygen saturation (ScvO2), Central venous oxygen&#xD;
      tension (Pvo2) and Central venous carbon dioxide tension (Pvco2). The central venous oxygen&#xD;
      content (Cvo2) Cvo2 = (1.34 × Svo2 × Hb) + (0.003 × Pvo2) Radial arterial canula was inserted&#xD;
      under ultrasound guidance to all patients and arterial blood gases (ABG) was analyzed at (T0)&#xD;
      and (T8) to measure: arterial oxygen tension (Pao2), arterial oxygen content (Cao2), arterial&#xD;
      carbon dioxide tension (Paco2), arterial oxygen saturation (Sao2.) and lactate level Cao2 =&#xD;
      (1.34 × Sao2 × Hb) + (0.003 × Pao2) Resuscitation Patients were randomly assigned (by&#xD;
      computer generated sequence) into three groups each consists of 40 patients: Group (1):&#xD;
      veno-arterial carbon dioxide tension / arteriovenous oxygen content P(v-a)CO2/C(a-v)O2 ratio&#xD;
      group; Group (2): Lactate clearance (LC) group; Lactate level was measured then LC rate was&#xD;
      calculated by the equation [(lactate(T0)- lactate(T8))/lactate(T0)] × 100%.&#xD;
&#xD;
      Group (3):&#xD;
&#xD;
      veno-arterial carbon dioxide tension group; P(v-a)co2 difference Measurements were obtained&#xD;
      at T0 (before the start of resuscitation) and at T8 (after 8 hours of the start of&#xD;
      resuscitation), the three groups received the same initial resuscitation protocol according&#xD;
      to Surviving Sepsis Campaign (9), the appropriate specimens were taken for aerobic and&#xD;
      anaerobic culture, empirical broad-spectrum antibiotics was given, source of infection was&#xD;
      controlled with removal of any old intravascular lines which may be the source of sepsis.&#xD;
&#xD;
      The early goals of resuscitation were to achieve the following: CVP of 8-12 cmH2O, MAP &gt; 65&#xD;
      mm Hg, a urine output &gt;0.5 mL/kg and Scvo2 of 70% or more, we started with 30 ml/kg&#xD;
      crystalloids in the first 3 hours, then we guided by hemodynamic status, if not achieved, we&#xD;
      were targeted by titrating vasopressors until MAP &gt; 65 mmHg by using either norepinephrine&#xD;
      (0.25 mcg /kg/min increasing every 15 min) or dobutamine (2.5 mcg/min every 15 min&#xD;
      increased). The patients connected to mechanical ventilation if needed with appropriate&#xD;
      settings, with minimal dose of sedation, blood glucose controlled and anticoagulant and&#xD;
      Proton pump inhibitors were administrated as a prophylaxis, early enteral nutrition was&#xD;
      initiated, if there was no contraindications Measured data&#xD;
&#xD;
      In group (1) we prepared this measures at T0 and T8:&#xD;
&#xD;
        -  The arteriovenous oxygen content difference (C(a-v)O2) C(a-v)O2 = Cao2 - Cvo2&#xD;
&#xD;
        -  The venoarterial CO2 tension difference (P(v-a)CO2) P(v-a)CO2 = Pvco2 - Paco2&#xD;
&#xD;
        -  P(v-a)CO2/C(a-v)O2 ratio&#xD;
&#xD;
             -  (Pvco2 - Paco2)/(Cao2 - Cvo2)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2021</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>in septic patients in intensive care unit and to evaluate the success of early resuscitation protocol</measure>
    <time_frame>3-4 monthes</time_frame>
    <description>success of early resuscitation</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Sepsis Syndrome</condition>
  <arm_group>
    <arm_group_label>group1</arm_group_label>
    <description>Group (1): veno-arterial carbon dioxide tension / arteriovenous oxygen content P(v-a)CO2/C(a-v)O2 ratio group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2</arm_group_label>
    <description>Group (2): Lactate clearance (LC) group; Lactate level was measured then LC rate was calculated by the equation [(lactate(T0)- lactate(T8))/lactate(T0)] × 100%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 3</arm_group_label>
    <description>Group (3):&#xD;
veno-arterial carbon dioxide tension group; P(v-a)co2 difference</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>lactat and blood gases</intervention_name>
    <description>observational</description>
    <arm_group_label>group 2</arm_group_label>
    <arm_group_label>group 3</arm_group_label>
    <arm_group_label>group1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        120 adult critically ill patients admitted to the ICU in Minia University Hospital.&#xD;
        Patients Ages was ≥ 18 and ≤ 65 years including both sexs, resuscitation started after&#xD;
        fulfilling the diagnostic criteria of sepsis issued by Surviving Sepsis Campaign 2016&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        adult critically ill patients admitted to the ICU in Minia University Hospital. Patients&#xD;
        Ages was ≥ 18 and ≤ 65 years including both sexs, resuscitation started after fulfilling&#xD;
        the diagnostic criteria of sepsis issued by Surviving Sepsis Campaign 2016&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  We excluded Patients with chronic organ failure (Cardiovascular, Respiratory, Liver,&#xD;
             Neurological and Renal.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>ahmed hassanein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minia University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ahmed hassanein, MD</last_name>
    <phone>01006946879</phone>
    <email>ahmedhassanein10@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>rehab mohamed, MD</last_name>
    <phone>01004407515</phone>
    <email>rehabmahamed820@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ahmed Hassanein</name>
      <address>
        <city>Minya</city>
        <zip>11116</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ahmed hassanein</last_name>
      <phone>01006946879</phone>
      <email>ahmedhassanein10@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>rehab mohamed</last_name>
      <phone>01004407515</phone>
      <email>rehabmohamed820@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 9, 2021</study_first_submitted>
  <study_first_submitted_qc>September 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Ahmed Hassanein Mohamed</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

